国际皮肤性病学杂志    0  (): 274-276   ISSN: 2096-5540  CN: 32-1880/R   慢性特发性荨麻疹的药物治疗进展 尚淑贤, 夏隆庆, 赵建斌, 王千秋 中国医学科学院、中国协和医科大学皮肤病研究所, 南京210042 收稿日期 2004-10-29  修回日期 null  网络版发布日期 null 参考文献  [1] Horak F, Stubner UP. Comparative tolerability of second generation antihistamines. Drug Saf, 1999, 20:385-401. [2] Gelfand EW, Appajosyula S, Meeves S. Anti-inflammatory activity of H1-R receptor antagonists:review of recent experimental research. Curr Med Res Opin, 2004, 20:73-81. [3] Kawashima M, Harada S, Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol, 2002, 41:701-781. [4] Ring J, Hein R, Gauger A, et al. Once-R daily desloratadine inproves the signs and symptoms of chronic idiopathic urticaria:a randomized, double-R blind, placebo-R controlled study. Int J Dermatol, 2001, 40:72-76. [5] Valk PJ, Van Roon DB, Simons RM, et al. Desloratadine shows no effect on performance during 6 h at 8,000 ft simulated cabin altitude. Aviat Space Environ Med, 2004, 75:433-438. [6] Henz BM. The pharmacologic profile of desloratadine:a review. Allergy, 2001, 56(Suppl65):7-13. [7] Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-R controlled trial comparing desloratadine and montelukast in monotherapy and desioratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol, 2004,114:619-625. [8] Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria:a single-R blind, placeboR controlled, crossover clinical study. J Allergy Clin Immunol,2002, 110:484-488. [9] Loria MP, Dambra PP, D'Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria:a therapeutic alternative.Immunopharmacol Immunotoxicol, 2001, 23:205-213. [10] Baskan EB, Tunali S, Turker T, et al. Comparison of short-R and long-R term cyclosporine A therapy in chronic idiopathic urticaria.J Dermatolog Treat, 2004, 15:164-168. [11] Grattan CE, O'Donnell BF, Francis DM, et al. Randomized doubleR blind study of cyclosporin in chronic "idiopathic"urticaria. Br J Dermatol, 2000, 143:365-372. [12] Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria:a double blind, placebo controlled trial. J Dermatol, 2001, 28:299-302. [13] Paradis L, Lavoie A, Brunet C, et al. Effects of systemic corticosteroids on cutaneous histamine secretion and histamine-R releasing factor in patients with chronic idiopathic urticaria. Clin Exp Allergy, 1996, 26:815-820. [14] Zauli D, Grassi A, Ballardini G, et al. Thyroid autoimmunity in chronic idiopathic urticaria:implications for therapy. Am J Clin Dermatol, 2002, 3:525-528. [15] Gaig P, Garcia-R Ortega P, Enrique E, et al. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity.J Investig Allergol Clin Immunol, 2000, 10:342-345. [16] Moreira A, Rodrigues J, Delgado L, et al. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr), 2003, 31:209-214. [17] Parslew R, Pryce D, Ashworth J,et al. Warfarin treatment of chronic idiopathic urticaria and angio-R oedema. Clin Exp Allergy, 2000,30:1161-1165. 通讯作者: